检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:叶瑞绒 谭彩萍[1] 计亮年[1] 毛宗万[1] YE Ruirong TAN Caiping JI Liangnian MAO Zongwan(School of Chemistry and Chemical Engineering, Sun Yat-Sen University, Guangzhou 510275, China)
机构地区:[1]中山大学化学与化学工程学院,广东广州510275
出 处:《药学进展》2017年第1期4-16,共13页Progress in Pharmaceutical Sciences
摘 要:顺铂及其衍生物在抗肿瘤方面取得了很大成功,但是传统的铂类抗癌药物的毒副作用和耐药性限制了这类化合物在临床上的进一步开发。近年来,非铂类化合物,如具有d6电子结构的磷光过渡金属钌(Ⅱ)、铱(Ⅲ)和铼(Ⅰ)配合物,由于其丰富的光物理和光化学性质、氧化还原性质、多样的几何构型和水溶性好等优势吸引了越来越多的关注。综述上述3种金属配合物在生物成像及抗肿瘤方面的研究进展。Despite the success of cisplatin and its derivatives in cancer therapy, the development of traditional platinum-based anticancer agents is hindered by serious side-effects and easily acquired drug resistance. Recently, non-platinum-based compounds such as Ru(Ⅱ ), Ir( Ⅲ ), and Re( Ⅰ ) complexes with d6 electronic structures have attracted increasing attention due to their varied photophysieal and photochemical properties, redox activities, geometrical diversity and good water solubility. This paper reviewed the recent progress in the development of phosphorescent transition- metal complexes as bioimaging agents and anticancer drugs.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222